I can't imagine anything coming out of investigati
Post# of 148177
Sp is low, but stable for an otc biotech imo. Volume is high compared to others. I wonder if this is because of shares being issued as apart of financing?
Not saying it is a bad thing. Just can't see retail offering so many shares every day for this long without significant swings.
If sp was $5 I would be waiting. At $1.50 I am waiting & buying. Time is on our side.